ID

17124

Description

Memantine as an Adjunctive Agent to Reduce Neurocognitive Deficits Following Unilateral ECT for the Treatment of a Severe Major Depressive Episode; ODM derived from: https://clinicaltrials.gov/show/NCT00186498

Lien

https://clinicaltrials.gov/show/NCT00186498

Mots-clés

Versions (1)
  1. 25/08/2016 25/08/2016 -
Téléchargé le

25 août 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Depressive Disorder, Major NCT00186498

Anglais

Eligibility Depressive Disorder, Major NCT00186498

1 Formulaires  
Criteria
Description

Criteria

meets dsm-iv criteria for major depressive disorder
Description

Major Depressive Disorder

Type de données

boolean

Alias
UMLS CUI [1]
C1269683
18 to 75 years of age and able to provide legal consent
Description

Age | Informed Consent

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C0021430
referred to stanford ect service by treating physician for unilateral electroconvulsive therapy with inpatient hospitalization
Description

Referral for Electroconvulsive Therapy Unilateral | Hospitalization

Type de données

boolean

Alias
UMLS CUI [1,1]
C2585524
UMLS CUI [1,2]
C0013806
UMLS CUI [1,3]
C0205092
UMLS CUI [2]
C0019993
competed process for consenting to the clinical use of ect according to california state law
Description

Electroconvulsive Therapy Consent Use Clinical

Type de données

boolean

Alias
UMLS CUI [1,1]
C0013806
UMLS CUI [1,2]
C1511481
UMLS CUI [1,3]
C0457083
UMLS CUI [1,4]
C0205210
females of childbearing potential will be required to use a double-barrier method of contraception, which includes foam and either condom and diaphragm, iud, and/or implant during study. exclusion criteria:- treatment with ect in the 6 months prior to screening
Description

Childbearing Potential Contraceptive methods | Contraception, Barrier | Vaginal Foam | Female Condoms | Vaginal contraceptive diaphragm | Intrauterine Devices | Contraceptive implant | Exclusion Criteria | Electroconvulsive Therapy

Type de données

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0700589
UMLS CUI [2]
C0004764
UMLS CUI [3]
C0042254
UMLS CUI [4]
C0221829
UMLS CUI [5]
C0042241
UMLS CUI [6]
C0021900
UMLS CUI [7]
C1657106
UMLS CUI [8]
C0680251
UMLS CUI [9]
C0013806
meets criteria for drug or alcohol abuse or dependence in the 6 months prior to screening
Description

Substance Use Disorders | Substance Dependence

Type de données

boolean

Alias
UMLS CUI [1]
C0038586
UMLS CUI [2]
C0038580
use of alcohol or illegal drugs within seven days of randomization or during study. patients may be excluded for use during a period greater than 7 days, per study physician's discretion
Description

Alcohol consumption | Illicit drug use

Type de données

boolean

Alias
UMLS CUI [1]
C0001948
UMLS CUI [2]
C0281875
presence of unstable or untreated cardiovascular disease, hypertension, or endocrine disorder as determined by the investigator
Description

Cardiovascular Disease Unstable | Hypertensive disease Unstable | Endocrine System Disease Unstable | Cardiovascular Disease untreated | hypertension untreated | Endocrine System Disease untreated

Type de données

boolean

Alias
UMLS CUI [1,1]
C0007222
UMLS CUI [1,2]
C0443343
UMLS CUI [2,1]
C0020538
UMLS CUI [2,2]
C0443343
UMLS CUI [3,1]
C0014130
UMLS CUI [3,2]
C0443343
UMLS CUI [4,1]
C0007222
UMLS CUI [4,2]
C0332155
UMLS CUI [5]
C0745134
UMLS CUI [6,1]
C0014130
UMLS CUI [6,2]
C0332155
use of antipsychotic, antidepressant, or other prescription medications unless dose is stable for at least 7 days prior to randomization.
Description

Antipsychotic Agents | Antidepressive Agents | Prescription medication Dosage Unstable

Type de données

boolean

Alias
UMLS CUI [1]
C0040615
UMLS CUI [2]
C0003289
UMLS CUI [3,1]
C0033080
UMLS CUI [3,2]
C0013227
UMLS CUI [3,3]
C0178602
UMLS CUI [3,4]
C0443343
use of any investigational treatment within 30 days of randomization
Description

Therapy, Investigational

Type de données

boolean

Alias
UMLS CUI [1]
C0949266
previous allergic reaction to memantine or drugs of similar chemical structure.
Description

Allergic Reaction Memantine | Allergic Reaction Pharmaceutical Preparations Chemical Structure Similar

Type de données

boolean

Alias
UMLS CUI [1,1]
C1527304
UMLS CUI [1,2]
C0025242
UMLS CUI [2,1]
C1527304
UMLS CUI [2,2]
C0013227
UMLS CUI [2,3]
C0220807
UMLS CUI [2,4]
C2348205
women who are pregnant or breastfeeding are not advised to participate in the research study
Description

Pregnancy | Breast Feeding

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
any neurological disorder or organic brain condition that would confound neurocognitive testing
Description

nervous system disorder Interferes with neurocognitive test | Organic brain disorder Interferes with neurocognitive test

Type de données

boolean

Alias
UMLS CUI [1,1]
C0027765
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C0872227
UMLS CUI [2,1]
C4062280
UMLS CUI [2,2]
C0521102
UMLS CUI [2,3]
C0872227
Retour au début de la page

Similar models

Eligibility Depressive Disorder, Major NCT00186498

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Major Depressive Disorder
Item
meets dsm-iv criteria for major depressive disorder
boolean
C1269683 (UMLS CUI [1])
Age | Informed Consent
Item
18 to 75 years of age and able to provide legal consent
boolean
C0001779 (UMLS CUI [1])
C0021430 (UMLS CUI [2])
Referral for Electroconvulsive Therapy Unilateral | Hospitalization
Item
referred to stanford ect service by treating physician for unilateral electroconvulsive therapy with inpatient hospitalization
boolean
C2585524 (UMLS CUI [1,1])
C0013806 (UMLS CUI [1,2])
C0205092 (UMLS CUI [1,3])
C0019993 (UMLS CUI [2])
Electroconvulsive Therapy Consent Use Clinical
Item
competed process for consenting to the clinical use of ect according to california state law
boolean
C0013806 (UMLS CUI [1,1])
C1511481 (UMLS CUI [1,2])
C0457083 (UMLS CUI [1,3])
C0205210 (UMLS CUI [1,4])
Childbearing Potential Contraceptive methods | Contraception, Barrier | Vaginal Foam | Female Condoms | Vaginal contraceptive diaphragm | Intrauterine Devices | Contraceptive implant | Exclusion Criteria | Electroconvulsive Therapy
Item
females of childbearing potential will be required to use a double-barrier method of contraception, which includes foam and either condom and diaphragm, iud, and/or implant during study. exclusion criteria:- treatment with ect in the 6 months prior to screening
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0004764 (UMLS CUI [2])
C0042254 (UMLS CUI [3])
C0221829 (UMLS CUI [4])
C0042241 (UMLS CUI [5])
C0021900 (UMLS CUI [6])
C1657106 (UMLS CUI [7])
C0680251 (UMLS CUI [8])
C0013806 (UMLS CUI [9])
Substance Use Disorders | Substance Dependence
Item
meets criteria for drug or alcohol abuse or dependence in the 6 months prior to screening
boolean
C0038586 (UMLS CUI [1])
C0038580 (UMLS CUI [2])
Alcohol consumption | Illicit drug use
Item
use of alcohol or illegal drugs within seven days of randomization or during study. patients may be excluded for use during a period greater than 7 days, per study physician's discretion
boolean
C0001948 (UMLS CUI [1])
C0281875 (UMLS CUI [2])
Cardiovascular Disease Unstable | Hypertensive disease Unstable | Endocrine System Disease Unstable | Cardiovascular Disease untreated | hypertension untreated | Endocrine System Disease untreated
Item
presence of unstable or untreated cardiovascular disease, hypertension, or endocrine disorder as determined by the investigator
boolean
C0007222 (UMLS CUI [1,1])
C0443343 (UMLS CUI [1,2])
C0020538 (UMLS CUI [2,1])
C0443343 (UMLS CUI [2,2])
C0014130 (UMLS CUI [3,1])
C0443343 (UMLS CUI [3,2])
C0007222 (UMLS CUI [4,1])
C0332155 (UMLS CUI [4,2])
C0745134 (UMLS CUI [5])
C0014130 (UMLS CUI [6,1])
C0332155 (UMLS CUI [6,2])
Antipsychotic Agents | Antidepressive Agents | Prescription medication Dosage Unstable
Item
use of antipsychotic, antidepressant, or other prescription medications unless dose is stable for at least 7 days prior to randomization.
boolean
C0040615 (UMLS CUI [1])
C0003289 (UMLS CUI [2])
C0033080 (UMLS CUI [3,1])
C0013227 (UMLS CUI [3,2])
C0178602 (UMLS CUI [3,3])
C0443343 (UMLS CUI [3,4])
Therapy, Investigational
Item
use of any investigational treatment within 30 days of randomization
boolean
C0949266 (UMLS CUI [1])
Allergic Reaction Memantine | Allergic Reaction Pharmaceutical Preparations Chemical Structure Similar
Item
previous allergic reaction to memantine or drugs of similar chemical structure.
boolean
C1527304 (UMLS CUI [1,1])
C0025242 (UMLS CUI [1,2])
C1527304 (UMLS CUI [2,1])
C0013227 (UMLS CUI [2,2])
C0220807 (UMLS CUI [2,3])
C2348205 (UMLS CUI [2,4])
Pregnancy | Breast Feeding
Item
women who are pregnant or breastfeeding are not advised to participate in the research study
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
nervous system disorder Interferes with neurocognitive test | Organic brain disorder Interferes with neurocognitive test
Item
any neurological disorder or organic brain condition that would confound neurocognitive testing
boolean
C0027765 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0872227 (UMLS CUI [1,3])
C4062280 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0872227 (UMLS CUI [2,3])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial